Baudax Bio, Inc. BXRXQ
—
0.00
0.00
NaN
as of 25 Sep
- Market cap
- —
- P/E
- 0.0×
Follow BXRXQ
Growth Flags
show if company had growth for consecutive years
| Older periods | Dec '22 | Mar '23 | Jun '23 | Sep '23 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
0.25 | 0.31 | 0.07 | 0.02 | |
Current Ratio |
0.30 | 0.33 | 0.09 | 0.07 | |
Net Debt/EBITDA |
(0.05) | (0.77) | (0.63) | (2.96) | |
Debt/Assets |
70.96% | 105.21% | 27.50% | 25.40% | |
Debt/Equity |
(0.29) | (1.02) | (0.55) | (0.51) | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.59 | (0.35) | 0.46 | 1.23 | |
Capex/Depreciation |
(0.01) | 0.00 | 0.00 | (0.16) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.21 | 0.30 | 0.60 | 0.62 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(44.27) | (1.70) | (0.69) | (0.30) | |
Capex per Share |
(0.06) | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(44.33) | (1.70) | (0.69) | (0.30) | |
Cash per Share |
15.84 | 1.64 | 0.29 | 0.05 | |
Shareholders Equity per Share |
(73.02) | (3.15) | (2.19) | (1.28) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(73.02) | (3.15) | (2.19) | (1.28) | |
Free Cash Flow |
(14.72) | (3.94) | (3.37) | (2.39) | |
Working Capital |
(15.11) | (8.26) | (18.60) | (17.71) | |
Capital Expenditures |
(0.02) | — | — | (0.02) | |
Net Current Asset Value |
(27.93) | (10.27) | (30.13) | (29.48) | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | — | — | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
2.33 | 3.56 | 4.45 | 5.72 | |
Average Assets |
31.65 | 27.94 | 31.08 | 19.05 | |
Average Common Equity |
(5.51) | 1.22 | (3.22) | (14.89) |
Columns are period end dates